BD to Present at Investor Healthcare Conferences

FRANKLIN LAKES, N.J., June 1 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson
and Company) (NYSE: BDX), a global medical technology company, announced today
that it would present at the following investor healthcare conferences in
June:
Goldman Sachs 30th Annual Global Healthcare Conference
June 10, 2009
11:40 a.m. EDT

8th Annual Needham Life Sciences Conference
June 11, 2009
10:00 a.m. EDT

A live webcast of BD's presentations can be accessed from the BD corporate
website at www.bd.com/investors. They will be available for replay for a
period of seven days.

BD is a leading global medical technology company that develops, manufactures
and sells medical devices, instrument systems and reagents. The Company is
dedicated to improving people's health throughout the world. BD is focused on
improving drug delivery, enhancing the quality and speed of diagnosing
infectious diseases and cancers, and advancing research, discovery and
production of new drugs and vaccines. BD's capabilities are instrumental in
combating many of the world's most pressing diseases. Founded in 1897 and
headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000
people in approximately 50 countries throughout the world. The Company serves
healthcare institutions, life science researchers, clinical laboratories, the
pharmaceutical industry and the general public. For more information, please
visit www.bd.com.

SOURCE BD (Becton, Dickinson and Company)

Patricia A. Spinella, Investor Relations, +1-201-847-5453, or Colleen T.
White, Corporate Communications, +1-201-847-5369